Target Product Profile: Ellen Feigal - 2011 CIRM Grantee Meeting

Ellen Feigal, MD, led a workshop at the 2011 CIRM Grantee Meeting on the Target Product Profile (TPP). The TPP is a methodology for summarizing a drug development program which can facilitate communication between the drug's sponsor and the Federal Drug Administration. Feigal is Senior Vice President, Research and Development at the California Institute for Regenerative Medicine (CIRM).

Disease Programs

Learn about how CIRM-funded stem cell research could generate treatments for many chronic diseases and injuries.

See disease fact sheets

CIRM Stem Cell Blog